Data presented as No. (%) unless otherwise indicated.

*Five patients were excluded for evaluation of coagulopathy due to lack of laboratory measurements collected in these patients for the coagulopathy parameters of fibrinogen, ferritin, D-dimer and partial thromboplastin time. These five were among the earliest to be treated in the trial and importantly had no manifestations of bleeding.

ALL, acute lymphoblastic leukemia; CAR, chimeric antigen receptor; CRS, cytokine release syndrome; DLBCL, diffuse large B-cell lymphoma; HSCT, hematopoietic stem cell transplantation; INR, international normalized ratio; LD, lymphodepletion ; LDH, lactate dehydrogenase; PCA, principle component analysis; VGEF, vascular endothelial growth factor.